{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:02:48Z","timestamp":1791291768576,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,22]],"date-time":"2018-12-22T00:00:00Z","timestamp":1545436800000},"content-version":"am","delay-in-days":324,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jpba.2017.12.023","type":"journal-article","created":{"date-parts":[[2017,12,11]],"date-time":"2017-12-11T20:20:24Z","timestamp":1513023624000},"page":"169-175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Liquid chromatography\u2013tandem mass spectrometric assay for the quantitation of the novel radiation protective agent and radiation mitigator JP4-039 in murine plasma"],"prefix":"10.1016","volume":"150","author":[{"given":"Susan","family":"Christner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Parise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Ringeval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam T.","family":"Hoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wipf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Epperly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel S.","family":"Greenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.","family":"Beumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L.","family":"Eiseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jpba.2017.12.023_bib0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2004.09.037","article-title":"Kinetics and mechanism of the comproportionation reaction between oxoammonium cation and hydroxylamine derived from cyclic nitroxides","volume":"38","author":"Israeli","year":"2005","journal-title":"Free Rad. Biol. Med."},{"issue":"1","key":"10.1016\/j.jpba.2017.12.023_bib0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/antiox4010082","article-title":"Antioxidant approaches to management of ionizing irradiation injury","volume":"4","author":"Greenberger","year":"2015","journal-title":"Antioxidants"},{"issue":"6","key":"10.1016\/j.jpba.2017.12.023_bib0015","first-page":"811","article-title":"Intraesophageal administration of GS-nitroxide (JP4-039) protects against ionizing irradiation-induced esophagitis","volume":"24","author":"Epperly","year":"2010","journal-title":"In Vivo"},{"issue":"4","key":"10.1016\/j.jpba.2017.12.023_bib0020","first-page":"435","article-title":"Esophageal radioprotection by swallowed JP4-039\/F15 in thoracic-irradiated mice with transgenic lung tumors","volume":"28","author":"Epperly","year":"2014","journal-title":"In Vivo"},{"issue":"11","key":"10.1016\/j.jpba.2017.12.023_bib0025","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.exphem.2013.08.001","article-title":"Evaluation of potential ionizing irradiation protectors and mitigators using clonogenic survival of human umbilical cord blood hematopoietic progenitor cells","volume":"41","author":"Goff","year":"2013","journal-title":"Exp. Hematol."},{"issue":"3","key":"10.1016\/j.jpba.2017.12.023_bib0030","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.ijrobp.2011.01.059","article-title":"Two strategies for the development of mitochondrion-targeted small molecule radiation damage mitigators","volume":"80","author":"Rwigema","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.jpba.2017.12.023_bib0035","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fonc.2014.00024","article-title":"Can radiosensitivity associated with defects in DNA repair be overcome by mitochondrial-targeted antioxidant radioprotectors","volume":"4","author":"Greenberger","year":"2014","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.jpba.2017.12.023_bib0040","first-page":"315","article-title":"Radiobiologic effects of GS-nitroxide (JP4-039) on the hematopoietic syndrome","volume":"25","author":"Goff","year":"2011","journal-title":"In Vivo"},{"key":"10.1016\/j.jpba.2017.12.023_bib0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jpba.2016.11.035","article-title":"LC-MS\/MS assay for the quantitation of the tyrosine kinase inhibitor neratinib in human plasma","volume":"134","author":"Kiesel","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.jpba.2017.12.023_bib0050","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00280-016-3181-9","article-title":"Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation","volume":"78","author":"Kiesel","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.jpba.2017.12.023_bib0055","series-title":"Guidance for Industry-Bioanalytical Method Validation","author":"U.S. Department of Health and Human Services Food and Drug Administration","year":"2001"},{"issue":"3","key":"10.1016\/j.jpba.2017.12.023_bib0060","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1081\/JLC-100101455","article-title":"Bioanalytical liquid chromatographic method validation. a review of current practices and procedures","volume":"23","author":"Rosing","year":"2000","journal-title":"J. Liquid Chromatogr. Relat. Technol."},{"issue":"6","key":"10.1016\/j.jpba.2017.12.023_bib0065","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/oxfordjournals.jbchem.a135000","article-title":"Studies on algal cytochromes. V. Purification and characterization of cytochrome c-552 from a red alga, Polysiphonia urceolata","volume":"96","author":"Sugimura","year":"1984","journal-title":"J. Biochem."},{"issue":"2","key":"10.1016\/j.jpba.2017.12.023_bib0070","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1208\/s12248-009-9100-9","article-title":"Workshop report and follow-up-AAPS workshop on current topics in GLP bioanalysis: assay reproducibility for incurred samples-implications of crystal city recommendations","volume":"11","author":"Fast","year":"2009","journal-title":"AAPS J."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517326055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708517326055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:36:15Z","timestamp":1759962975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708517326055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":14,"alternative-id":["S0731708517326055"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2017.12.023","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid chromatography\u2013tandem mass spectrometric assay for the quantitation of the novel radiation protective agent and radiation mitigator JP4-039 in murine plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2017.12.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}